147 related articles for article (PubMed ID: 36134036)
1. Chemotherapy for Metastatic Gastric Cancer: Does Age Matter? A Single-Center, Retrospective, Real-World Study.
Liao PW; Cheng SB; Chou CW; Lin HC; Lin CH; Chen TC; Hsu CY; Jerry Teng CL; Shih YH
Clin Med Insights Oncol; 2022; 16():11795549221123617. PubMed ID: 36134036
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study.
Bozkurt O; Firat ST; Dogan E; Cosar R; Inanc M; Ozkan M
J BUON; 2019; 24(5):1992-1999. PubMed ID: 31786866
[TBL] [Abstract][Full Text] [Related]
4. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
[TBL] [Abstract][Full Text] [Related]
5. A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients.
Yang LP; Wang ZX; He MM; Wu HX; Yuan SQ; Wang W; Jin Y; Ren C; Wang ZQ; Wang FH; Li YH; Wang F; Xu RH
Cancer Manag Res; 2019; 11():3993-4003. PubMed ID: 31118812
[No Abstract] [Full Text] [Related]
6. The Prognostic Value of Neutrophil-to-lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Metastatic Gastric Cancer Treated with Systemic Chemotherapy.
Zhou D; Wu Y; Zhu Y; Lin Z; Yu D; Zhang T
J Cancer; 2020; 11(14):4205-4212. PubMed ID: 32368303
[No Abstract] [Full Text] [Related]
7. Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis.
Lin JX; Wang ZK; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
Cancer Commun (Lond); 2019 Feb; 39(1):4. PubMed ID: 30744696
[TBL] [Abstract][Full Text] [Related]
8. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
9. Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.
Hwang JE; Kim HN; Kim DE; Choi HJ; Jung SH; Shim HJ; Bae WK; Hwang EC; Cho SH; Chung IJ
BMC Cancer; 2011 Nov; 11():489. PubMed ID: 22103888
[TBL] [Abstract][Full Text] [Related]
10. Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy.
Petrillo A; Laterza MM; Tirino G; Pompella L; Ventriglia J; Pappalardo A; Famiglietti V; Martinelli E; Ciardiello F; Orditura M; Galizia G; De Vita F
Future Oncol; 2018 Oct; 14(24):2493-2505. PubMed ID: 29969285
[TBL] [Abstract][Full Text] [Related]
11. The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer.
Zainal Abidin MN; Omar MS; Islahudin F; Mohamed Shah N
BMC Cancer; 2022 Jul; 22(1):731. PubMed ID: 35787795
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer.
Badora-Rybicka A; Nowara E; Starzyczny-Słota D
ESMO Open; 2016; 1(2):e000039. PubMed ID: 27843595
[TBL] [Abstract][Full Text] [Related]
13. Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.
Jin H; Zhang G; Liu X; Liu X; Chen C; Yu H; Huang X; Zhang Q; Yu J
World J Surg Oncol; 2013 May; 11():112. PubMed ID: 23705622
[TBL] [Abstract][Full Text] [Related]
14. A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphoma.
Liu P; Han Y; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Zhou LQ; Yang JL; Yang S; Wen TY; Shi YK
Chin Med J (Engl); 2019 Aug; 132(15):1807-1814. PubMed ID: 31335477
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer.
Thol F; Gairing SJ; Czauderna C; Thomaidis T; Gamstätter T; Huber Y; Vollmar J; Lorenz J; Michel M; Bartsch F; Müller L; Kloeckner R; Galle PR; Wörns MA; Marquardt JU; Moehler M; Weinmann A; Foerster F
JHEP Rep; 2022 Mar; 4(3):100417. PubMed ID: 35141511
[TBL] [Abstract][Full Text] [Related]
16. Population-based outcomes research on treatment patterns and impact of chemotherapy in older patients with metastatic gastric cancer.
Lee KW; Lee JH; Kim JW; Kim JW; Ahn S; Kim JH
J Cancer Res Clin Oncol; 2016 Mar; 142(3):687-97. PubMed ID: 26567125
[TBL] [Abstract][Full Text] [Related]
17. First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status.
Hwang JE; Kim HN; Kim DE; Shim HJ; Bae WK; Hwang EC; Cho SH; Chung IJ
Exp Ther Med; 2012 Oct; 4(4):562-568. PubMed ID: 23170106
[TBL] [Abstract][Full Text] [Related]
18. Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer.
Hsu JT; Liao JA; Chuang HC; Chen TD; Chen TH; Kuo CJ; Lin CJ; Chou WC; Yeh TS; Jan YY
BMC Palliat Care; 2017 Mar; 16(1):19. PubMed ID: 28288593
[TBL] [Abstract][Full Text] [Related]
19. The neutrophil-to-lymphocyte ratio prechemotherapy and postchemotherapy as a prognostic marker in metastatic gastric cancer.
Kim H; Ro SM; Yang JH; Jeong JW; Lee JE; Roh SY; Kim IH
Korean J Intern Med; 2018 Sep; 33(5):990-999. PubMed ID: 29722249
[TBL] [Abstract][Full Text] [Related]
20. The impact of granulocyte colony-stimulating factor use in patients with metastatic breast cancer treated with palliative chemotherapy: a single-institution retrospective review.
Mousa L; Stephens JA; Berger M; Ramaswamy B; Lustberg M; Sardesai S; Williams N; VanDeusen J; Stover D; Cherian M; Morgan E; Wesolowski R
Support Care Cancer; 2020 Nov; 28(11):5537-5545. PubMed ID: 32185556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
